Avid Bioservices Inc (CDMO)

[Big On Tarvy]

Back in late June I heard that M.D. Anderson was “taking the cancer trial to the next level.” In the context I understood that remark to mean enrollment was going faster. I heard nothing to the effect the size of the trial has been enlarged (e.g. to 30-40 patients) or that a higher dose level was added.

Then in the July 14 CC three weeks later SK said:

“Accelerating enrollment trends at some of our centers are encouraging.”

I am quite sure SK was referring to accelerating enrollment at M.D. Anderson.
SK also said in the next breath of the CC:

“We believe Bavituximab has the potential to be a major cancer drug.”

I strongly suspect SK’s belief in Bavi as a “major cancer drug” comes from encouraging reports he has heard out of M.D. Anderson. . Docs at research hospitals enroll patients faster in a particular trial when they see good results coming from that trial.